milgamma 300 mg
milgamma 300 mg is a medicine authorised by Swissmedic under authorisation number 68695. The authorisation holder is Biomed AG. The medicinal product code is Synthetic medicines and the dispensing category is D: Supplied in pharmacies and drugstores after specialist advice, without a prescription. First authorisation was granted on 06 April 2023 and the authorisation is limited until 05 April 2028. The export lists no ATC code for this medicine.
| Authorisation number | 68695 |
|---|---|
| Name | milgamma 300 mg |
| Full name | milgamma 300 mg, Filmtabletten |
| Authorisation holder | Biomed AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | D · No prescription, with advice |
| ATC code | not stated |
| First authorisation | 06 April 2023 |
| Authorisation validity | 05 April 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | milgamma 300 mg, Filmtabletten | D | 06 April 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| The Swissmedic export lists no pack sizes for this medicine. | |||||
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is milgamma 300 mg authorised in Switzerland?
Yes. milgamma 300 mg is authorised by Swissmedic under authorisation number 68695, data as of 01 September 2026. The authorisation is limited until 05 April 2028.
Which dispensing category does milgamma 300 mg have?
milgamma 300 mg is in dispensing category D. Supplied in pharmacies and drugstores after specialist advice, without a prescription.
Who is the authorisation holder of milgamma 300 mg?
The authorisation holder is Biomed AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.